6/30/2014 8:16:20 AM
NEW YORK, June 27, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced that it will be added to the Russell 3000® and Russell 2000® Indexes today, Friday, June 27, 2014, when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes.
Help employers find you! Check out all the jobs and post your resume.
comments powered by